|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical outcomes after percutaneous or surgical revascularization of unprotected left main coronary artery-related acute myocardial infarction:a single-center experience显示文摘 | Grundeken M J Vis M M Beijk M A | 2013 | Heart2013，99，10： | 1 |
| 2 | Two-year clinical, an- giographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions:the SPIRIT II trial 显示文摘 | Claessen B E Beijk M A Legrand V | 2009 | Circulation2009，2，4： | 1 |
| 3 | p27kip1–838C>A Single Nucleotide Polymorphism Is Associated With Restenosis Risk After Coronary Stenting and Modulates p27kip1 Promoter Activity显示文摘 | Claudia M. van Tiel Peter I. Bonta Saskia Z.H. Rittersma Marcel A.M. Beijk Edward J. Bradley Anita M. Klous Karel T. Koch Frank Baas J Wouter Jukema Douwe Pons M Lourdes Sampietro Hans Pannekoek Robbert J. de Winter Carlie J.M. de Vries | 2009 | Circulation2009，，： | 1 |
| 4 | Genous endothelial progenitor cell-capturing stent system: a novel stent technology显示文摘 | Klomp M Beijk MA de Winter RJ | 2009 | Ex pert Rev Med Devices2009，6，4： | 1 |
| 5 | A systematic review and meta-analysis on primary percutaneous coronary intervention of an unprotected left main coronary artery culprit lesion in the set- ting of acute myocardial infarction显示文摘 | Vis MM Beijk MA Grundeken M J | 2013 | Jacc Cardiovascular Interven- tions2013，6，4： | 1 |
| 6 | XIENCE V everolimus - eluting coronary stent system : a novel second generation drug-eluting stent 显示文摘 | Beijk MA Piek JJ | 2007 | Expert Rev Med Devices2007，4，1： | 1 |
| 7 | Clinical outcomes after bare-metal stenting in diabetic patients with lesions carrying a low risk of restenosis显示文摘 | Woudstra P Damman P Beijk MA | 2013 | Catheter Cardiovasc Interv2013，81，： | 1 |
| 8 | Long-term follow-upafter nonurgent percutaneous coronary intervention in unprotectedleft main coronary arteries显示文摘 | Beijk M A Rittersma S Z Koch K T | 2010 | Catheter Cardiovasc Interv2010，75，7： | 1 |
| 9 | XIENCE V everolimus -eluting coronary stent system: a novel second generation drug-eluting stent 显示文摘 | Beijk MA Piek JJ | 2007 | Expert Rev Med Devices2007，4，1： | 1 |
| 10 | Clinical outcomes afterPercutaneous or surgical revascularisation of unprotected left main coronary artery-related acute myocardial infarction:a singlecentre experience显示文摘 | Grundeken M J Vis MM Beijk MA | | 0，，： | 1 |
| 11 | XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent显示文摘 | Beijk MA Piek JJ | 2007 | Expert Rev Med Devices2007，4，1： | 1 |
| 12 | Two-year Iol- low-up of the GenousTM endothelial progenitor cell cap- turing stent versus the Taxus Libertstent in patients with de novo coroenary artery lesions with a high-risk of rest- enosis : A randomized, single-center, pilot study显示文摘 | Beijk MA Klomp M van Geloven N | 2011 | Cathe- ter Cardiovasc Interv2011，78，2： | 1 |
| 13 | 1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter,randomized trial comparing ge- nous endothelial progenitor cell capturing stents with drug-eluting stents 显示文摘 | Klomp M Beijk MA Varma C | 2011 | JACC Cardiovasc Interv2011，4，8： | 1 |
| 14 | Two-year clinical, an- giographic, and intravaseular ultrasound follow-up of the XIENCE V everolimus-eluting steut in the treatment of patients with de no- vo native coronary artery lesions:the SPIRIT 11 trial 显示文摘 | Claessen B E Beijk M A Legrand V | 2009 | Circ Cardiovasc lnterv2009，2，4： | 1 |
| 15 | Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native cor- onary arterylesions: the SPIRIT II trial 显示文摘 | Claessen BE Beijk MA Legrand V | 2009 | Circ Cardiovasc Interv2009，2，4： | 1 |
| 16 | 1-Year Outcome of TRIAS HR (TRI-Stent Adjudication Study–High Risk of Restenosis)显示文摘 | Margo Klomp Marcel A. Beijk Chetan Varma Jacques J. Koolen Emmanuel Teiger Gert Richardt Florian Bea Nan van Geloven Niels J. Verouden Yu Kwan Chan Pier Woudstra Peter Damman Jan G. Tijssen Robbert J. de Winter | 2011 | JACC: Cardiovascular Interventions2011，，8： | 1 |
| 17 | Three-year clinical follow-up of an unselected patient population treated with the genous endothe- lial progenitor cell capturing stent显示文摘 | Klomp M Beijk MA Damman P | 2011 | J Interv Cardiol2011，24，5： | 1 |
| 18 | Individuals at in- creased coronary heart disease risk are characterized by an impaired microvascular function in skin 显示文摘 | Ijzerman RG de Jongh RT Beijk MA | 2003 | Eur J Clin Invest2003，33，7： | 1 |
| 19 | Two-year clinical,angiographic,and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions:the SPIRIT Ⅱ trial显示文摘 | Claessen BE Beijk MA Legrand V | | 0，，04： | 1 |
| 20 | XIENCE V everolimus-eluting coronary stent system: a novel second Generation drug-eluting stent 显示文摘 | Beijk MA Piek JJ | 2007 | Expert Rev Med Devices2007，4，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员